Analysis of MLL amplification and 5q deletions in AML/MDS cell lines identifies novel targets.

被引：0
|
作者：
Schneider, Bjoem
Nagel, Stefan
Kaufmann, Maren
Quentmeier, Hilmar
Matsuo, Yoshinobu
Drexler, Hans G.
MacLeod, Roderick A. F.
机构：
[1] German Collect Microorganisms & Cell Cultures, Human Animal Cell Cultures, Braunschweig, Germany
[2] Grandsoul Res Inst Immunol, Nara, Japan
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.1424.1424
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1424
引用
收藏
页码：413A / 414A
页数：2
相关论文
共 18 条
  • [1] Analysis of AML/MDS cell lines highlights genes targeted by concomitant 5q deletion and 11q23 amplification
    Schneider, B.
    Nagel, S.
    Kaufmann, M.
    Drexler, H. G.
    MacLeod, R. A. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 48 - 48
  • [2] GENE TARGETS OF 11Q23 AMPLIFICATION AND CONCOMITANT 5Q DELETION IN AML/MDS CELLS
    Schneider, B.
    Geffers, R.
    Quentmeier, H.
    Kaufmann, M.
    Nagel, S.
    Drexler, H. G.
    MacLeod, R. A. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 12 - 12
  • [3] Deletions of 5q Promote Genome Instability in TP53-Mutant MDS/AML
    Reilly, Andreea
    Busch, Stephanie
    Abkowitz, Janis L.
    Becker, Pamela S.
    Doulatov, Sergei
    BLOOD, 2019, 134
  • [4] Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients
    Douet-Guilbert, N.
    De Braekeleer, E.
    Basinko, A.
    Herry, A.
    Gueganic, N.
    Bovo, C.
    Trillet, K.
    Dos Santos, A.
    Le Bris, M. J.
    Morel, F.
    Eveillard, J. R.
    Berthou, C.
    De Braekeleer, M.
    LEUKEMIA, 2012, 26 (07) : 1695 - 1697
  • [5] Molecular characterization of deletions of the long arm of chromosome 5 (del(5q)) in 94 MDS/AML patients
    N Douet-Guilbert
    E De Braekeleer
    A Basinko
    A Herry
    N Gueganic
    C Bovo
    K Trillet
    A Dos Santos
    M J Le Bris
    F Morel
    J R Eveillard
    C Berthou
    M De Braekeleer
    Leukemia, 2012, 26 : 1695 - 1697
  • [6] FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes
    Lessard, M
    Herry, A
    Berthou, C
    Léglise, MC
    Abgrall, JF
    Morice, P
    Flandrin, G
    LEUKEMIA RESEARCH, 1998, 22 (04) : 303 - 312
  • [7] 5q deletions can be identified based on the expression level of 5q genes: A study on 49 cases with MDS or AML analysed in parallel by gene expression profiling and genomic
    Schoch, Claudia
    Rauhut, Sonja
    Schnittger, Susanne
    Dicker, Frank
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2006, 108 (11) : 746A - 747A
  • [8] Gene expression profiling in AML and MDS identifies genes located on 5q which are consistently lower expressed in cases with 5q deletion as compared to cases with normal karyotype.
    Schoch, C
    Kohlmann, A
    Kern, W
    Merk, S
    Hiddemann, W
    Dugas, M
    Schnittger, S
    Haferlach, T
    BLOOD, 2004, 104 (11) : 159A - 159A
  • [9] Cytogenetic, spectral karyotyping, fluorescence in situ hybridization, and comparative genomic hybridization characterization of two new secondary leukemia cell lines with 5q deletions, and MYC and MLL amplification (vol 37, pg 270, 2003)
    Knutsen, T
    Pack, S
    Petropavlovskaja, M
    Padilla-Nash, H
    Knight, C
    Mickley, LA
    Ried, T
    Elwood, PC
    Roberts, SJ
    GENES CHROMOSOMES & CANCER, 2003, 37 (03): : 332 - 332
  • [10] Tifab, a Novel Candidate Gene in Deletion Chromosome 5q, Contributes to Deregulation of NF-κB Signaling in MDS/AML.
    Varney, Melinda
    Jerez, Andres
    Fang, Jing
    Miller, David
    Bolanos, Lyndsey
    Karsan, Aly
    Maciejewski, Jaroslaw P.
    Starczynowski, Daniel T.
    BLOOD, 2012, 120 (21)
12